Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 113016 | 131.185 |
09:34 ET | 7884 | 130.68 |
09:36 ET | 5366 | 130.72 |
09:38 ET | 13773 | 130.05 |
09:39 ET | 26165 | 129.92 |
09:41 ET | 15029 | 129.92 |
09:43 ET | 9710 | 130.04 |
09:45 ET | 5546 | 130.234 |
09:48 ET | 4927 | 130.5681 |
09:50 ET | 4219 | 130.285 |
09:52 ET | 7667 | 129.99 |
09:54 ET | 6528 | 130.65 |
09:56 ET | 1848 | 130.49 |
09:57 ET | 2763 | 130.21 |
09:59 ET | 7800 | 130.25 |
10:01 ET | 10421 | 130.6083 |
10:03 ET | 8614 | 130.9299 |
10:06 ET | 5562 | 130.8598 |
10:08 ET | 12094 | 130.845 |
10:10 ET | 12266 | 131.01 |
10:12 ET | 8278 | 130.91 |
10:14 ET | 3066 | 131.1199 |
10:15 ET | 4942 | 131.2933 |
10:17 ET | 7133 | 131.3 |
10:19 ET | 8110 | 131.14 |
10:21 ET | 4515 | 131.27 |
10:24 ET | 7685 | 131.25 |
10:26 ET | 4480 | 131.41 |
10:28 ET | 6073 | 131.3 |
10:30 ET | 4459 | 131.43 |
10:32 ET | 9615 | 131.42 |
10:33 ET | 9208 | 131.6699 |
10:35 ET | 11146 | 131.65 |
10:37 ET | 4822 | 131.51 |
10:39 ET | 60858 | 131.295 |
10:42 ET | 47793 | 131.3 |
10:44 ET | 5833 | 131.86 |
10:46 ET | 8584 | 131.7783 |
10:48 ET | 10870 | 132.04 |
10:50 ET | 9548 | 132.17 |
10:51 ET | 8465 | 132.28 |
10:53 ET | 6178 | 132.315 |
10:55 ET | 8829 | 132.52 |
10:57 ET | 5824 | 132.275 |
11:00 ET | 3789 | 132.21 |
11:02 ET | 1630 | 132.2 |
11:04 ET | 2914 | 132 |
11:06 ET | 4035 | 131.705 |
11:08 ET | 4107 | 131.54 |
11:09 ET | 3006 | 131.63 |
11:11 ET | 1723 | 131.78 |
11:13 ET | 3013 | 131.9547 |
11:15 ET | 4061 | 132.04 |
11:18 ET | 1361 | 132.05 |
11:20 ET | 1569 | 132.2 |
11:22 ET | 6789 | 132.24 |
11:24 ET | 2672 | 132.33 |
11:26 ET | 1723 | 132.37 |
11:27 ET | 6750 | 132.61 |
11:29 ET | 6377 | 132.495 |
11:31 ET | 2684 | 132.405 |
11:33 ET | 1515 | 132.31 |
11:36 ET | 6218 | 132.4 |
11:38 ET | 2310 | 132.26 |
11:40 ET | 6193 | 132.61 |
11:42 ET | 6635 | 132.59 |
11:44 ET | 8407 | 132.79 |
11:45 ET | 4803 | 132.97 |
11:47 ET | 4929 | 132.7683 |
11:49 ET | 2025 | 132.5 |
11:51 ET | 41089 | 133.14 |
11:54 ET | 28665 | 132.95 |
11:56 ET | 2980 | 133.31 |
11:58 ET | 7694 | 133.215 |
12:00 ET | 6459 | 133.26 |
12:02 ET | 5875 | 133.41 |
12:03 ET | 3948 | 133.44 |
12:05 ET | 1959 | 133.36 |
12:07 ET | 4100 | 133.51 |
12:09 ET | 1650 | 133.35 |
12:12 ET | 3876 | 133.44 |
12:14 ET | 11638 | 133.5351 |
12:16 ET | 7290 | 133.4283 |
12:18 ET | 8464 | 133.33 |
12:20 ET | 2113 | 133.54 |
12:21 ET | 5280 | 133.39 |
12:23 ET | 1960 | 133.35 |
12:25 ET | 3935 | 133.4953 |
12:27 ET | 4794 | 133.7201 |
12:30 ET | 16047 | 133.86 |
12:32 ET | 9050 | 133.86 |
12:34 ET | 6476 | 133.98 |
12:36 ET | 10550 | 134.06 |
12:38 ET | 4762 | 134.16 |
12:39 ET | 4901 | 134.25 |
12:41 ET | 12423 | 134.215 |
12:43 ET | 15881 | 134.51 |
12:45 ET | 13732 | 134.29 |
12:48 ET | 15110 | 133.91 |
12:50 ET | 12021 | 133.84 |
12:52 ET | 2616 | 133.745 |
12:54 ET | 5197 | 133.905 |
12:56 ET | 3109 | 133.9628 |
12:57 ET | 16504 | 134.32 |
12:59 ET | 23829 | 134.365 |
01:01 ET | 6986 | 133.98 |
01:03 ET | 5164 | 133.95 |
01:06 ET | 4877 | 133.82 |
01:08 ET | 2495 | 133.7511 |
01:10 ET | 4248 | 133.88 |
01:12 ET | 4421 | 133.8 |
01:14 ET | 4278 | 133.645 |
01:15 ET | 2322 | 133.9 |
01:17 ET | 894 | 133.74 |
01:19 ET | 2608 | 133.65 |
01:21 ET | 4112 | 133.4426 |
01:24 ET | 3381 | 133.73 |
01:26 ET | 1253 | 133.8 |
01:28 ET | 2583 | 133.77 |
01:30 ET | 10966 | 133.44 |
01:32 ET | 7428 | 133.3751 |
01:33 ET | 1610 | 133.318 |
01:35 ET | 7727 | 133.45 |
01:37 ET | 9225 | 133.42 |
01:39 ET | 3343 | 133.455 |
01:42 ET | 15593 | 133.46 |
01:44 ET | 3784 | 133.5699 |
01:46 ET | 6740 | 133.295 |
01:48 ET | 3023 | 133.3 |
01:50 ET | 3120 | 133.31 |
01:51 ET | 5254 | 133.315 |
01:53 ET | 10078 | 133.07 |
01:55 ET | 4697 | 133.06 |
01:57 ET | 7023 | 133.09 |
02:00 ET | 12260 | 133.33 |
02:02 ET | 18212 | 133.23 |
02:04 ET | 8449 | 132.86 |
02:06 ET | 8867 | 132.65 |
02:08 ET | 11079 | 132.2 |
02:09 ET | 3949 | 132.3525 |
02:11 ET | 6337 | 132.4953 |
02:13 ET | 4057 | 132.455 |
02:15 ET | 3134 | 132.18 |
02:18 ET | 8574 | 132.315 |
02:20 ET | 3152 | 132.13 |
02:22 ET | 2505 | 132.0665 |
02:24 ET | 4908 | 132.16 |
02:26 ET | 1126 | 132.26 |
02:27 ET | 520 | 132.33 |
02:29 ET | 1436 | 132.3499 |
02:31 ET | 6734 | 132.04 |
02:33 ET | 1200 | 132.025 |
02:36 ET | 2769 | 132.02 |
02:38 ET | 7825 | 131.92 |
02:40 ET | 4294 | 131.98 |
02:42 ET | 2958 | 131.86 |
02:44 ET | 2000 | 131.85 |
02:45 ET | 2655 | 131.68 |
02:47 ET | 7540 | 131.71 |
02:49 ET | 6682 | 131.94 |
02:51 ET | 26151 | 132.045 |
02:54 ET | 3021 | 132.01 |
02:56 ET | 8185 | 132.045 |
02:58 ET | 5880 | 132.015 |
03:00 ET | 1886 | 131.91 |
03:02 ET | 5696 | 131.96 |
03:03 ET | 5985 | 132.01 |
03:05 ET | 4218 | 131.856 |
03:07 ET | 1792 | 131.8425 |
03:09 ET | 3987 | 131.99 |
03:12 ET | 3749 | 132.04 |
03:14 ET | 2673 | 131.975 |
03:16 ET | 2415 | 132 |
03:18 ET | 4609 | 132.0249 |
03:20 ET | 7882 | 132.0317 |
03:21 ET | 8500 | 132.05 |
03:23 ET | 9326 | 132.42 |
03:25 ET | 3908 | 132.39 |
03:27 ET | 3228 | 132.26 |
03:30 ET | 1795 | 132.305 |
03:32 ET | 2995 | 132.3384 |
03:34 ET | 3739 | 132.15 |
03:36 ET | 2489 | 132.08 |
03:38 ET | 2086 | 132.17 |
03:39 ET | 3947 | 132.35 |
03:41 ET | 5592 | 132.3699 |
03:43 ET | 8444 | 132.33 |
03:45 ET | 2915 | 132.27 |
03:48 ET | 4837 | 132.44 |
03:50 ET | 10196 | 132.63 |
03:52 ET | 14234 | 132.69 |
03:54 ET | 8754 | 132.77 |
03:56 ET | 18411 | 132.76 |
03:57 ET | 27985 | 132.86 |
03:59 ET | 47071 | 132.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 50.8B | -8.5x | --- |
ICON PLC | 26.1B | 38.2x | +4.68% |
Biogen Inc | 33.5B | 28.8x | -18.14% |
Biontech SE | 22.1B | 175.3x | --- |
Grifols SA | 6.6B | 78.6x | --- |
Charles River Laboratories International Inc | 11.6B | 26.0x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.8B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.52 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -8.5x |
Price/Sales (TTM) | 9.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.